Business and Finance

Home » Business and Finance

Ono Pharmaceutical Shows Strength in Strategic Alliance Deals

A lucrative licensing agreement deal was announced on 12 October between US-based Karyopharm Therapeutics and Japan’s Ono Pharmaceutical for the development and commercialization of Karyopharm’s lead novel compound selinexor and KPT-8602, which are indicated for all oncology indications for Japan, South Korea, Taiwan, Hong Kong and AESEAN countries, according to GlobalData, a leading data and analytics company. [...]

Pharma Integrates 2017 Delivers a Strong Message to Industry

Returning to London for its landmark sixth year, the annual Pharma Integrates event, which took place on 15–16 November at the Grange City Hotel, drew top-tier, straight-talking industry experts to the stage to tackle the critical issues of the moment With 372 attendees, 99 speakers, 31 sponsors and 14 channel partners in one place, Pharma [...]

Oxford Genetics Licenses SnapFast Expression Vectors to Twist Bioscience

Oxford Genetics, a leader in innovative synthetic, biology based technologies for biologics discovery, development and delivery, has announced a new licensing agreement with Twist Bioscience Corporation, a company enabling customers to succeed through its offering of rapid, high-quality synthetic DNA. Oxford Genetics will supply Twist Bioscience with its SnapFast technology platform to provide a broad range of [...]

Recipharm to End Operations in Two Facilities in Sweden

Recipharm has announced that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in Stockholm and Höganäs, Sweden. Since 2015, Recipharm has been implementing efficiency activities in the Swedish part of the business segment known as Solids and Others. These initiatives have included a reduction in headcount and the [...]

Sciformix Corporation Collaborates with Oracle Health Sciences to Offer Full Service Validated Argus Enterprise Edition Drug Safety Solutions

Sciformix Corporation, a leading scientific knowledge-based organisation, is proud to announce its adoption of Oracle Argus Enterprise Edition platform to offer superior value to their customers in the life science industry. Through its collaboration with Oracle Health Sciences, Sciformix is able to offer its customers a fully automated and integrated safety database solution, allowing easy [...]

Capsugel Announces Expanded Capabilities for Clinical Trial Services and High-Potency Compounds at Edinburgh Facility

Capsugel, now a Lonza company, a global leader in delivering high-quality, innovative dosage forms and solutions, has announced expanded clinical trial capabilities, as well as increased development and manufacturing capabilities for specialised drug products utilising liquid-filled hard capsule (LFHC) technology, at its Edinburgh facility in Scotland. Enhanced Clinical Trial Services Offering Capsugel is enhancing its [...]

Catalent Completes Acquisition of Cook Pharmica

Catalent, Inc., the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has completed the acquisition of Cook Pharmica LLC, an integrated provider of drug substance and drug product manufacturing and related services. The acquisition of this Bloomington, Indiana-based biologics contract development and manufacturing organisation substantially strengthens [...]

Ardena Launches Following Pharmavize and Crystallics Merger

A new early phase contract development and manufacturing organisation (CDMO), Ardena, has launched following the merging of Pharmavize and Crystallics. The two companies came together in 2016 with backing from investor Mentha Capital. The new brand name, Ardena, reveals the increased service offering and complementary capabilities of Pharmavize in Belgium and Crystallics in the Netherlands. [...]

Clinigen Acquires Japan’s Largest Supplier of Unlicensed Medicines

Clinigen Group, the global pharmaceutical and services company, has acquired International Medical Management Corporation (IMMC), Japan’s largest supplier of unlicensed medicines, for an undisclosed sum. The acquisition will add to Clinigen’s existing footprint in the country following the launch of its Japanese business in October 2016. The acquisition of IMMC is part of Clinigen’s strategy [...]

Molecule to Market: PCI Affirms Position as Market-Leading Pharmaceutical Outsourcing Provider

Leading pharmaceutical services provider PCI Pharma Services will be at CPhI Worldwide (October 24-26, Frankfurt, Germany, Stand 4.F30), reinforcing its reputation for providing the global healthcare industry with excellence in service delivery. An ongoing strategic investment and expansion programme has enabled PCI to build its market-leading position enabling drug development solutions from molecule to market [...]